Trial Profile
A multi-centre, randomised clinical trial examining the effect of Clopidogrel versus Aspirin in addition to optimal medical therapy for heart failure on subsequent heart failure hospitalisation and mortality in patients with class III-IV congestive heart failure.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2019
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Aspirin
- Indications Heart failure
- Focus Therapeutic Use
- Acronyms CACHE
- 24 Apr 2019 Status has been changed to discontinued due Participant recruitment issue.
- 30 Jan 2014 Accrual to date is 2% according to United Kingdom Clinical Research Network record.
- 30 Jan 2014 Planned End Date changed from 31 Aug 2016 to 21 Jan 2013 according to United Kingdom Clinical Research Network record .